Development and validation of viral load assays to quantitate SARS-CoV-2

Area of Science:

• Virology
• Infectious Diseases
• Molecular Biology

Background:

• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused a global pandemic, with many patients requiring hospitalization and intensive care.
• Current diagnostic tests for SARS-CoV-2 provide qualitative results, limiting their utility in monitoring disease progression and treatment response.
• Quantitative assessment of viral load is crucial for evaluating therapeutic efficacy, understanding viral evolution, and assessing infection impact on organ systems.

Purpose of the Study:

• To develop and validate quantitative assays for measuring SARS-CoV-2 viral load.
• To provide tools for monitoring viral dynamics and guiding clinical management of SARS-CoV-2 infections.

Main Methods:

• Development of two quantitative assays targeting the S gene and E gene of SARS-CoV-2.
• Validation of assay sensitivity, specificity, and quantitation range.
• Application of assays to body fluids, plasma, and tissue samples.

Main Results:

• The developed assays accurately quantify SARS-CoV-2 viral load.
• Assays targeting S and E genes produced comparable results.
• Demonstrated high sensitivity, specificity, and a wide dynamic range for quantitation.

Conclusions:

• The new quantitative assays offer a reliable method for measuring SARS-CoV-2 viral load.
• These assays can aid in managing clinical outcomes for infected patients.
• The tools may enhance understanding of SARS-CoV-2 infection biology and pathogenesis.